Updated Jan 31, 2007 at 14:47 EST.
Two large clinical trials demonstrate that dapoxetine (
Priligy TM ), the first medication designed specifically to treat premature ejaculation, has potential to provide relief to more than 30% of men who suffer with the condition. The trials examined results from more than 2,600 men who reported moderate to severe premature ejaculation.
On-demand dosing of dapoxetine increased ejaculation latency time from the pre-study time of approximately one minute to just over three minutes. Despite the side effects, researchers believe the medication shows promise. The lead researcher, Dr. Jon Pryor noted in a press release, “Dapoxetine (
Priligy TM ) also improved patients’ perceptions of control over ejaculation, satisfaction with sexual intercourse, and overall impression of change in condition.”
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
